Patient characteristics
| Characteristic . | Value . |
|---|---|
| Median age, y (range) | 59.6 (23-81) |
| Sex, no. (%) | |
| Female | 14 (31) |
| Male | 31 (69) |
| Median bone marrow blasts, % (range) | 62.2 (25-91) |
| FAB, no. (%) | |
| M0-M1 | 8 (18) |
| M2 | 6 (13) |
| M3 | 4 (9) |
| M4-M5 | 24 (53) |
| Unknown | 3 (7) |
| Cytogenetics, no. (%) | |
| Normal karyotype | 31 (69) |
| FLT3-ITD | 12 |
| FLT3-TDK | 7 |
| NPM1 | 20 |
| inv16 | 2 (4) |
| t(11q23) | 6 (13) |
| t(8;21) | 1 (2) |
| t(15;17) | 4 (9) |
| del9q | 1 (2) |
| Characteristic . | Value . |
|---|---|
| Median age, y (range) | 59.6 (23-81) |
| Sex, no. (%) | |
| Female | 14 (31) |
| Male | 31 (69) |
| Median bone marrow blasts, % (range) | 62.2 (25-91) |
| FAB, no. (%) | |
| M0-M1 | 8 (18) |
| M2 | 6 (13) |
| M3 | 4 (9) |
| M4-M5 | 24 (53) |
| Unknown | 3 (7) |
| Cytogenetics, no. (%) | |
| Normal karyotype | 31 (69) |
| FLT3-ITD | 12 |
| FLT3-TDK | 7 |
| NPM1 | 20 |
| inv16 | 2 (4) |
| t(11q23) | 6 (13) |
| t(8;21) | 1 (2) |
| t(15;17) | 4 (9) |
| del9q | 1 (2) |